Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment
Explore an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers
![[wpbb post:title]](https://isoplexis.com/wp-content/uploads/2019/07/Webinar-Website-Covers-4.30_Artboard-10.png)
Dr. Naval Daver, Associate Professor, Department of Leukemia, MD Anderson Cancer Center
Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy
Explore relevant biomarker strategies associated with these approaches
See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival
